Carcinoma, Ovarian Epithelial: all 1,619 studies
Page 11 of 17. Open to participants first (245), then studies with results posted, then the rest; newest registration first within each.
- Study of SC-003 Alone and in Combination With ABBV-181 in Subjects With Platinum-Resistant/Refractory Ovarian CancerTerminatedNCT02539719Phase 1
- Study of Prolanta™ in Recurrent or Persistent Epithelial Ovarian CancerStatus unknownNCT02534922Phase 1
- Mesenchymal Stem Cells (MSC) for Ovarian CancerCompletedNCT02530047Phase 1
- WISER After Ovarian Cancer - Exercise Pilot StudyCompletedNCT02529150Not applicable
- Prospective Identification and Validation of "BRCANess" Profile in Ovarian Epithelial CancerStatus unknownNCT02524808
- Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian CancerCompletedNCT02520115Phase 1
- Lavage of the Uterine Cavity for the Diagnosis of Ovarian and Tubal Carcinoma - Study of Sensitivity and SpecificityCompletedNCT02518256Not applicable
- C-PATROL - Non-interventional Study (NIS) to Collect Clinical and Patient Reported Outcome Data in an Olaparib Treated BRCAm+ PSR Ovarian Cancer PopulationCompletedNCT02503436
- Masitinib in Combination With Gemcitabine in Advanced/Metastatic Epithelial Ovarian Cancer PatientsCompletedNCT02490488Phase 2/3
- A Study of Long-Term Responders on OlaparibCompletedNCT02489058
- HIPEC After Secondary Cytoreductive Operation in Patients With Platinum-sensitive Recurrence of Ovarian CarcinomaWithdrawnNCT02487849Phase 2
- Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Ovarian CarcinomaActive, not recruitingNCT02487693Phase 2
- Veliparib in Combination With Carboplatin And Weekly Paclitaxel in Japanese Subjects With Ovarian CancerCompletedNCT02483104Phase 1
- Safety, Tolerance, PK, and Anti-tumour Activity of AZD1775 Monotherapy in Patients With Advanced Solid TumoursCompletedNCT02482311Phase 1
- TIL Therapy for Metastatic Ovarian CancerCompletedNCT02482090Phase 1
- Venous Thromboembolic Complications in Ovarian CancerStatus unknownNCT02480790
- Study of Safety & Biological Activity of IP IMNN-001 (also Known As GEN-1) with Neoadjuvant Chemo in Ovarian CancerCompletedNCT02480374Phase 1
- Platine, Avastin and OLAparib in 1st LineCompletedNCT02477644Phase 3
- A Study With Intraperitoneal Cisplatin and Doxorubicin in Recurrent Ovarian Cancer and Peritoneal CarcinomatosisCompletedNCT02475772Phase 1
- Activated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer That is Stage III-IV, Refractory, or RecurrentWithdrawnNCT02470559Phase 1
- Autologous OC-L Vaccine and Ovarian CancerTerminatedNCT02452775Phase 1
- Detection of Tumor Associated Cell-free DNA in Peritoneal Fluid Obtained by CuldocentesisTerminatedNCT02441140Not applicable
- Study of Paclitaxel, Carboplatin and Oral Metformin in the Treatment of Advanced Stage Ovarian CarcinomaStatus unknownNCT02437812Phase 2
- p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal CancerStatus unknownNCT02435186Phase 2
- Observational Retrospective Study on Treatment and Outcomes in Patients With Low-grade Serous Ovarian CancerStatus unknownNCT02408536
- Taking Care of Her Program in Patients With Stage III or IV Ovarian Cancer and Spouse CaregiversCompletedNCT02401321Not applicable
- Tocotrienol as a Nutritional Supplement in Patients With Advanced Ovarian CancerCompletedNCT02399592Phase 2
- Retrospective Study to Analyze the Efficacy and Safety of Trabectedin and Pegylated Liposomal Doxorubicin (PLD ) in the Treatment of Patients With Platinum-sensitive Recurrent Ovarian Cancer (ROC), According to SmPCCompletedNCT02394015
- BELOVA Data Collection: Safety and Efficacy of Frontline Bevacizumab Treatment in Participants With Ovarian Cancer 70 Years and OlderCompletedNCT02393898
- Olaparib Maintenance Treatment Versus Placebo in Patients With PSR Ovarian Cancer Who Are in CR or PR to Platinum-based Chemotherapy and Whose Tumours Carry sBRCAm or HRR-associated Genes MutationsWithdrawnNCT02392676Phase 3
- Paclitaxel/Pazopanib for Platinum Resistant/Refractory Ovarian CancerCompletedNCT02383251Phase 2
- To Evaluate Plasmajet in Achieving Complete Cytoreduction of Advanced EOC- Initial Feasibility StudyCompletedNCT02376231Not applicable
- Salpingectomy at Cesarean Delivery for Ovarian Cancer Reduction (SCORE)CompletedNCT02374827Not applicable
- Niraparib Versus Niraparib-bevacizumab Combination in Women With Platinum-sensitive Epithelial Ovarian CancerCompletedNCT02354131Phase 1/2
- A Trial of Weekly Paclitaxel With Oncothermia and Weekly cisPlatin With Oncothermia in Patients With Recurrent or Persistent Ovarian CancerCompletedNCT02344095Phase 1
- Detection of Chlamydia DNA by Polymerase Chain Reaction in Primary Tubal and Ovarian Cancers Tissues : a Pilot StudyCompletedNCT02343510
- Capturing BRCA1/2 Mutational Status in Women With High Grade Serous Ovarian Cancer and Impact on Clinical Outcome.TerminatedNCT02341118
- A Study of Cediranib and Olaparib at the Time Ovarian Cancer Worsens on OlaparibCompletedNCT02340611Phase 2
- Cytoreduction With or Without Intraoperative Intraperitoneal Hyperthermic Chemotherapy (HIPEC) in Patients With Peritoneal Carcinomatosis From Ovarian Cancer, Fallopian Tube or Primary Peritoneal CarcinomaStatus unknownNCT02328716Phase 3
- Flaxseed as Maintenance Therapy for Ovarian Cancer Patients in RemissionCompletedNCT02324439Phase 1
- Live After an Epithelial Ovarian Cancer: Multidisciplinary Assessment of Effects and Long-term Remission in Patients Needs.CompletedNCT02323568Not applicable
- DOD Long-Term Survivors of Ovarian CancerStatus unknownNCT02321735Not applicable
- Talazoparib in Determining Genetic Effects on Disease Response in Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT02316834Early Phase 1
- Study of Metformin With Carboplatin/Paclitaxel Chemotherapy in Patients With Advanced Ovarian CancerCompletedNCT02312661Phase 1
- Yoga Practice for Breast or Ovarian Cancer PatientsCompletedNCT02305498Not applicable
- Safety and Efficacy Study of Nuc-1031 and Carboplatin Combination to Treat Recurrent Ovarian CancerCompletedNCT02303912Phase 1
- Individualised Versus Conventional Medical Follow-up for Women After Primary Treatment for Ovarian Cancer.CompletedNCT02298855Not applicable
- Impact of Fas/FasL in Chemotherapy Response in Epithelial Ovarian CarcinomaCompletedNCT02297958
- Perioperative Assessment of Right Ventricular Function and Venous Return in Patients With Epithelial Ovarian Cancer Undergoing Cytoreductive Surgery (Gyn Right) - Pilot StudyWithdrawnNCT02291276
- Sexual Therapy and Rehabilitation After Treatment for Ovarian Cancer (START-OC): A Pilot InterventionCompletedNCT02287519Not applicable
- p53MVA Vaccine and Gemcitabine Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial CancerCompletedNCT02275039Phase 1
- Study of ONT-10 and Varlilumab to Treat Advanced Ovarian or Breast CancerCompletedNCT02270372Phase 1
- Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid TumorsCompletedNCT02262455Phase 1
- OSCA - Olaparib Standard of CAre StudyCompletedNCT02262273
- Bioequivalence Study of Doxorubicin Hydrochloride Liposome InjectionCompletedNCT02260544Phase 1
- Impact of Gated PET/CT in the Diagnosis of Advanced Ovarian CancerCompletedNCT02258165
- Short-course HIPEC in Advanced Epithelial Ovarian CancerCompletedNCT02249013Phase 2
- Safety, Feasibility and Effect of TTFields (200 kHz) Concomitant With Weekly Paclitaxel in Recurrent Ovarian Carcinoma (INNOVATE)Status unknownNCT02244502Phase 1/2
- Assess Bioequivalence of Two Formulations of Doxorubicin Hydrochloride Liposome in Female Patients With Ovarian CancerCompletedNCT02237690Phase 1
- Prevalence of BRCA in Patients With Ovarian CancerCompletedNCT02222883
- Study Into a New Diagnostic Tool (Simple Ultrasound-based Rules) in Patients With Adnexal MassesTerminatedNCT02218502Not applicable
- Single Arm Trial With Combination of Everolimus and Letrozole in Treatment of Platinum Resistant Relapse or Refractory or Persistent Ovarian Cancer/Endometrial CancerStatus unknownNCT02188550Phase 2
- Ovarian Cancer Treatment Platinum-sensitive Relapse - Cohort Study (PROSPECTYON)CompletedNCT02163720
- CART-meso in Mesothelin Expressing CancersCompletedNCT02159716Phase 1
- Why do Oral Contraceptives Prevent Ovarian Cancer?CompletedNCT02155777Early Phase 1
- An Observational Study of Avastin (Bevacizumab) in Patients With Ovarian CancerCompletedNCT02151370
- Benchmarking Intra-tumor Heterogeneity In Ovarian Cancer: Linking In-vivo Imaging Phenotypes With Histology And GenomicsCompletedNCT02144311Not applicable
- The Efficacy of Involved-field Radiation Therapy for Residual or Locoregionally Recurrent Epithelial Ovarian Cancer After Definitive Treatment; Multi-institutional Clinical TrialCompletedNCT02135523Not applicable
- Decision Support Following Genetic Testing for Breast-Ovarian Cancer SusceptibilityCompletedNCT02133703Not applicable
- Trial of Active Immunotherapy With Globo H-KLH (OPT-822/821) in Women Who Have Non-Progressive Ovarian CancerStatus unknownNCT02132988Phase 2
- Neoadjuvant Chemotherapy in Epithelial Ovarian CancerStatus unknownNCT02125513Phase 2
- HOT: HIPEC in Ovarian Cancer as Initial TreatmentActive, not recruitingNCT02124421Phase 2
- OVArian Cancer Non-Interventional Study - OVATARCompletedNCT02122588
- Phase I BKM120/Abraxane in Solid Tumors, Expansion Phase Recurrent Endometrial or Ovarian CancerWithdrawnNCT02117817Phase 1
- Phase II Study DCVAC/OvCa Plus Carboplatin Gemcitabine Relapsed Platinum (Pt)-Sensitive Epithelial Ovarian CarcinomaCompletedNCT02107950Phase 2
- Phase II Study DCVAC/OvCa Added to First Line Carboplatin and Paclitaxel Newly Diagnosed Epithelial Ovarian CarcinomaCompletedNCT02107937Phase 2
- Efficacy of DCVAC/OvCa Plus Standard of Care in Relapsed Platinum Resistant Epithelial Ovarian CarcinomaTerminatedNCT02107378Phase 2
- Women's Activity and Lifestyle Study in ConnecticutCompletedNCT02107066Phase 3
- Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic CancerCompletedNCT02096783Not applicable
- A Phase 1 Trial of Perfusion Induced Systemic Hyperthermia (PISH) Over Multiple Cycles for Terminal Ovarian CancerSuspendedNCT02093871Phase 1
- Dose Escalation Study of OMP-54F28 in Combination With Paclitaxel and Carboplatin in Patients With Recurrent Platinum-Sensitive Ovarian CancerCompletedNCT02092363Phase 1
- H.O.P.E: Helping Ovarian Cancer Patients CopeCompletedNCT02090582Not applicable
- Prophylactic Salpingectomy for the Prevention of the Ovarian Cancer: Comparison Between Surgical TechniquesCompletedNCT02086370Not applicable
- LDFWART With Docetaxel in Patients With Platinum-Resistant Recurrent Ovarian CarcinomaWithdrawnNCT02083536Phase 1
- Survivorship Care Planning in Improving Quality of Life in Survivors of Ovarian CancerCompletedNCT02082470Not applicable
- A Study of DOXIL/CAELYX in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian CancerCompletedNCT02081495Phase 1
- Blood Collection From People With Ovarian CancerCompletedNCT02063464
- Lavage of the Uterine Cavity for the Diagnosis of Ovarian and Tubal Carcinoma and Their Premalignant Changes.CompletedNCT02062697Not applicable
- PAZOFOS: Phase Ib and Phase II Trial of Pazopanib +/- Fosbretabulin in Advanced Recurrent Ovarian CancerTerminatedNCT02055690Phase 1/2
- Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerWithdrawnNCT02050009Phase 1
- Carboplatin, Gemcitabine Hydrochloride, and Mifepristone in Treating Patients With Advanced Breast Cancer or Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT02046421Phase 1
- Epacadostat Before Surgery in Treating Patients With Newly Diagnosed Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT02042430Early Phase 1
- Lavage of the Uterine Cavity for the Diagnosis of Serous Tubal Intraepithelial CarcinomaCompletedNCT02039388Not applicable
- Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Advanced Epithelial Ovarian CarcinomasStatus unknownNCT02033616Phase 2
- Phase I / Dose Expansion Study of Enadenotucirev in Ovarian Cancer PatientsCompletedNCT02028117Phase 1
- A Phase II Study of Docetaxel and Carboplatin in Late Relapse of Ovarian CancerCompletedNCT02026921Phase 2
- Postoperative Adjuvant Chemotherapy With Bevacizumab and Maintenance Bevacizumab After Neoadjuvant Chemotherapy for Ovarian CancerCompletedNCT02022917Phase 2
- Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological CancersCompletedNCT02020707Phase 1
- Phase Ib Trial of Two Folate Binding Protein Peptide Vaccines (E39 and J65) in Breast and Ovarian Cancer PatientsCompletedNCT02019524Phase 1
- Phase 2 Study of JX-594 in Patients With Peritoneal Carcinomatosis of Ovarian Cancer OriginWithdrawnNCT02017678Phase 2